Skip to main content
Top
Published in: Journal of Natural Medicines 3-4/2011

01-07-2011 | Note

Preventive effects of the extract of kinka-cha, a folk tea, on a rat model of metabolic syndrome

Authors: Hisae Oku, Yuko Ogawa, Emiko Iwaoka, Yu Yamaguchi, Satomi Kagota, Shinozuka Kazumasa, Masaru Kunitomo, Kyoko Ishiguro

Published in: Journal of Natural Medicines | Issue 3-4/2011

Login to get access

Abstract

Kinka-cha (dried leaf of Camellia nitidissima) is used as a folk tea for detoxication, diuresis and antihypertension. In the present study, we evaluated the extract of kinka-cha on metabolic, vascular and oxidative stress parameters in a model of metabolic syndrome, SHR/NDmcr-cp/cp (SHR/cp) rats that manifest hypertension, obesity, glucose intolerance and hyperlipidemia. Treatment with the extract of kinka-cha alleviated the increase in blood pressure, decrease in tail blood flow and elevated serum oxidative stress marker levels including lipid peroxides, 8-hydroxy-2′-deoxyguanosine, 3-nitrotyrosine and 3-chlorotyrosine. However, kinka-cha did not affect weight gain, hyperglycemia and hyperlipidemia, nor the relaxation responses of the aorta mesenteric artery, thoracic aortas and tail vein, and blood clotting and platelet aggregation. These results suggest that kinka-cha can help reduce the risk of developing metabolic syndrome, possibly due to the presence of antioxidants.
Literature
1.
go back to reference Michaelis OE, Ellwood KC, Judge JM, Schoene NW, Hansen CT (1984) Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes. Am J Clin Nutr 39:612–618PubMed Michaelis OE, Ellwood KC, Judge JM, Schoene NW, Hansen CT (1984) Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes. Am J Clin Nutr 39:612–618PubMed
2.
go back to reference Striffler JB, Bhathena SJ, Micaelis OE IV, Campbell JD, Hansen CT, Scalbert E, Thibault N, Velasquez MT (1998) Role of angiotensin-converting enzyme inhibition in glucose metabolism and renal injury in diabetes. Metabolism 47:1199–1204PubMedCrossRef Striffler JB, Bhathena SJ, Micaelis OE IV, Campbell JD, Hansen CT, Scalbert E, Thibault N, Velasquez MT (1998) Role of angiotensin-converting enzyme inhibition in glucose metabolism and renal injury in diabetes. Metabolism 47:1199–1204PubMedCrossRef
3.
go back to reference Nagase M, Fujita T (2010) Mineralocorticoid receptor activation in obesity hypertension. Hypertens Res 32:649–657CrossRef Nagase M, Fujita T (2010) Mineralocorticoid receptor activation in obesity hypertension. Hypertens Res 32:649–657CrossRef
4.
go back to reference Yamaguchi Y, Yoshikawa N, Kagota S, Nakamura K, Haginaka J, Kunitomo M (2006) Elevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome. Nitric Oxide 15:380–386PubMedCrossRef Yamaguchi Y, Yoshikawa N, Kagota S, Nakamura K, Haginaka J, Kunitomo M (2006) Elevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome. Nitric Oxide 15:380–386PubMedCrossRef
5.
go back to reference Kagota S, Yamaguchi Y, Tanaka N, Kubta Y, Kobayashi K, Nejime N, Nakamura K, Kunitomo M, Shinozuka K (2006) Disturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci 78:1187–1196PubMedCrossRef Kagota S, Yamaguchi Y, Tanaka N, Kubta Y, Kobayashi K, Nejime N, Nakamura K, Kunitomo M, Shinozuka K (2006) Disturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci 78:1187–1196PubMedCrossRef
6.
go back to reference Kudo M, Noshiro M, Aoyama Y, Yoshida Y (2004) Studies on the expression levels of sterol-metabolizing enzymes in the obese model SHR/NDmcr-cp rats. Clin Exp Pharmacol Physiol 34:S57–S59CrossRef Kudo M, Noshiro M, Aoyama Y, Yoshida Y (2004) Studies on the expression levels of sterol-metabolizing enzymes in the obese model SHR/NDmcr-cp rats. Clin Exp Pharmacol Physiol 34:S57–S59CrossRef
7.
go back to reference Harikai N, Hashimoto A, Semma M, Ichikawa A (2007) Characteristics of lipolysis in white adipose tissues of SHR/NDmc-cp rats, a model of metabolic syndrome. Metab Clin Exp 56:847–855PubMed Harikai N, Hashimoto A, Semma M, Ichikawa A (2007) Characteristics of lipolysis in white adipose tissues of SHR/NDmc-cp rats, a model of metabolic syndrome. Metab Clin Exp 56:847–855PubMed
8.
go back to reference Oku H, Ogawa Y, Iwaoka E, Ishiguro K (2007) Development of an in vivo bioassay method for primary preventive substances of the metabolic syndrome—effect of kinginka-cha. Clin Exp Pharmacol Physiol 34:S40–S42CrossRef Oku H, Ogawa Y, Iwaoka E, Ishiguro K (2007) Development of an in vivo bioassay method for primary preventive substances of the metabolic syndrome—effect of kinginka-cha. Clin Exp Pharmacol Physiol 34:S40–S42CrossRef
9.
go back to reference Huang Y, Wen Y, Chen Y, Tang W, Li D, Liu J, Wei X (2009) Extraction technology and dynamic change of flavonoids in Camellia nitidissima leaves. Shipin Kexue 30:72–75 Huang Y, Wen Y, Chen Y, Tang W, Li D, Liu J, Wei X (2009) Extraction technology and dynamic change of flavonoids in Camellia nitidissima leaves. Shipin Kexue 30:72–75
10.
go back to reference Huang Y, Chen Y, Wen Y, Li D, Liu J, Wei X (2009) Analysis of volatile components in Camellia nitidissima by GC-MS. Shipin Keji 34:257–260 Huang Y, Chen Y, Wen Y, Li D, Liu J, Wei X (2009) Analysis of volatile components in Camellia nitidissima by GC-MS. Shipin Keji 34:257–260
11.
go back to reference Liang J, Yang Z, Lu T, Huang S (1999) Evaluation on tea-process fitness of eight yellow Camellias based on tea polyphenols and amino acids. Guangxi Sci 6:72–74 Liang J, Yang Z, Lu T, Huang S (1999) Evaluation on tea-process fitness of eight yellow Camellias based on tea polyphenols and amino acids. Guangxi Sci 6:72–74
12.
go back to reference Yagi K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15:212–216PubMedCrossRef Yagi K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15:212–216PubMedCrossRef
13.
go back to reference Long L, McCabe DR, Dolan ME (1999) Determination of 8-oxoguanine in human plasma and urine by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 731:241–249PubMedCrossRef Long L, McCabe DR, Dolan ME (1999) Determination of 8-oxoguanine in human plasma and urine by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 731:241–249PubMedCrossRef
14.
go back to reference Ishiguro K, Oku H, Ueda Y, Iwaoka E, Kunitomo M (2005) Development of an in vivo bioassay method for allergy-preventive substances using hen-egg white lysozyme (HEL)-induced blood flow decrease. Biol Pharm Bull 28:1490–1495PubMedCrossRef Ishiguro K, Oku H, Ueda Y, Iwaoka E, Kunitomo M (2005) Development of an in vivo bioassay method for allergy-preventive substances using hen-egg white lysozyme (HEL)-induced blood flow decrease. Biol Pharm Bull 28:1490–1495PubMedCrossRef
15.
go back to reference Ogawa Y, Oku H, Iwaoka E, Iinuma M, Ishiguro K (2006) Allergy-preventive phenolic glycosides from Populus sieboldii. J Nat Prod 69:1215–1217PubMedCrossRef Ogawa Y, Oku H, Iwaoka E, Iinuma M, Ishiguro K (2006) Allergy-preventive phenolic glycosides from Populus sieboldii. J Nat Prod 69:1215–1217PubMedCrossRef
16.
go back to reference Lind L, Lithell H (1993) Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J 125:1494–1497PubMedCrossRef Lind L, Lithell H (1993) Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J 125:1494–1497PubMedCrossRef
17.
go back to reference Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL (2000) Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 36:957–964PubMed Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL (2000) Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 36:957–964PubMed
18.
go back to reference Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393–397PubMedCrossRef Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393–397PubMedCrossRef
19.
go back to reference Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, Belaaouaj A, Heinecke JW (2002) Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 109:1311–1319PubMed Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, Belaaouaj A, Heinecke JW (2002) Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 109:1311–1319PubMed
Metadata
Title
Preventive effects of the extract of kinka-cha, a folk tea, on a rat model of metabolic syndrome
Authors
Hisae Oku
Yuko Ogawa
Emiko Iwaoka
Yu Yamaguchi
Satomi Kagota
Shinozuka Kazumasa
Masaru Kunitomo
Kyoko Ishiguro
Publication date
01-07-2011
Publisher
Springer Japan
Published in
Journal of Natural Medicines / Issue 3-4/2011
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-011-0523-0

Other articles of this Issue 3-4/2011

Journal of Natural Medicines 3-4/2011 Go to the issue